About: Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease; as well as DMX-652 for the treatment of acute kidney injury. The company is headquartered in Fitzroy, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.21 (-2.33%)
DXB ASX Dimerix Ltd
Carregando status da lista de acompanhamento…
Dimerix Ltd share price
Atividade de preço de DXB
Último preço
$ 0,210
Variação (24h)
-0,01 AUD (2,33%)
Volume
333.87K
Volume (média 4 sem.)
-
Abertura
$ 0,22
Variação do dia
$ 0,21 - $ 0,22
Fechamento anterior
$ 0,22
Último negócio
30 Oct, 5:10 am GMT+0
Atrasado
30 Oct, 5:10 am GMT+0
DXB price performance
+5,00%
5D
-10,64%
1M
-61,82%
YTD
-58,82%
1Y
Atrasado
30 Oct, 5:10 am GMT+0
quote.marketSignals